BATON ROUGE, La. (WAFB) - Atrial Fibrillation, or AFib is the leading cause of stroke. The American Heart Association says five million Americans currently have AFib, with an additional 12 million ...

DEAR DR. ROACH: I am a 70-year old woman with a prior history of asymptomatic atrial fibrillation (AFib). I’ve been in normal sinus rhythm since having two catheter ablations in 2018. I take Eliquis ...

Baptist Heart & Vascular Institute cardiologists, advanced practice providers and BHVI leadership recently gathered to celebrate the performance of its 1,000th Watchman procedure. The procedure is a ...

Data also demonstrates that the stroke risk reduction device is as effective as oral anticoagulants for patients with atrial fibrillation following a cardiac ablation The trial met the primary safety ...

LAKE CHARLES, La. (KPLC) - A big milestone happened over at CHRISTUS Ochsner St. Patrick Hospital this week. Their cardiology team announced they have implanted 500 Watchman devices for patients with ...

New stroke risk reduction therapy with thromboresistant coating is designed to advance procedural performance and safety MARLBOROUGH, Mass., Sept. 6, 2023 /PRNewswire/ -- Boston Scientific Corporation ...

SHREVEPORT, La. (KTAL/KMSS) — CHRISTUS Shreveport-Bossier Health System have announced their 500th successful implant of a breakthrough cardiac procedure that can reduce the risk of a stroke.

Medicare covers Watchman surgery if it is deemed medically necessary to reduce stroke risk in people with nonvalvular atrial fibrillation. Medicare parts A and B and Medicare Advantage may cover ...

The Cottage Heart & Vascular Center’s structural heart team at Santa Barbara Cottage Hospital (SBCH) recently performed their 1,000th WATCHMAN device procedure, a minimally invasive solution for ...

When David Reed was first diagnosed with atrial fibrillation (AFib), the treatment felt more unsettling than the disease. The most common form of heart arrhythmia, AFib prompts the heart’s upper ...

Boston Scientific Corp. reported positive data for two key atrial fibrillation therapies at AF Symposium 2025 on January 17. In late-breaking data presentations, the ADVANTAGE AF trial for the ...

MedStar Heart & Vascular Institute now offers patients with irregular heart rhythm a minimally invasive option to reduce the risk of stroke, as well as enable stopping long-term use of blood thinning ...